Ophthalmology, Cornea and External Diseases Specialist · Bronx, NY
NPI
1104054139
Since 2009
Specialty
Ophthalmology, Cornea and External Diseases Specialist
Code 207WX0120X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3332 Rochambeau Ave
Bronx, NY, 10467
Phone (718) 920-2020
Groups this clinician bills Medicare through
Medicare paid, 2024
$110K
1,096 services
Medicare patients, 2024
459
Average age 72
Drug cost, 2024
$1.4M
7,135 prescriptions
Company payments, 2025
$278
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joann Kang was code 99213 (office e&m - established), 177 times for 154 patients. In total Joann Kang billed 1,096 services in 32 codes, and Medicare paid $110K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-04-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 177 | 154 | $53.61 | $9,489 |
| 99214 Office E&M - Established | Facility | 148 | 117 | $83.02 | $12K |
| 99213 Office E&M - Established | Office | 85 | 73 | $50.87 | $4,324 |
| 99214 Office E&M - Established | Office | 76 | 64 | $81.62 | $6,203 |
| 66984 Cataract Surgery | Facility | 62 | 47 | $495.43 | $31K |
| 92083 Vision, Hearing, and Speech Services | Facility | 55 | 53 | $21.67 | $1,192 |
| 92133 Computerized Ophthalmic Imaging | Facility | 51 | 50 | $17.64 | $899 |
| 92136 Ultrasound - Nonspecific | Facility | 49 | 39 | $25.91 | $1,269 |
| 92083 Vision, Hearing, and Speech Services | Office | 39 | 36 | $24.12 | $941 |
| 92133 Computerized Ophthalmic Imaging | Office | 39 | 36 | $18.81 | $734 |
| 92136 Ultrasound - Nonspecific | Office | 31 | 26 | $26.56 | $823 |
| 92134 Computerized Ophthalmic Imaging | Facility | 27 | 25 | $20.14 | $544 |
| 99203 Office E&M - New | Facility | 26 | 26 | $62.34 | $1,621 |
| 99204 Office E&M - New | Office | 24 | 24 | $110.38 | $2,649 |
| 76514 Ultrasound - Nonspecific | Office | 21 | 21 | $7.26 | $152 |
By year: 2022 $89K for 892 services; 2023 $114K for 1,200 services; 2024 $110K for 1,096 services.
Medicare prescription drug claims, 2024
In 2024, the drug Joann Kang prescribed most often to Medicare patients was Latanoprost, with 1,687 prescriptions and refills. In total Joann Kang wrote 7,135 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 1,687 | 2,063 | 300 | $11K |
| Prednisolone Acetate Generic | 1,425 | 2,330 | 546 | $77K |
| Restasis Cyclosporine | 989 | 1,109 | 252 | $658K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 607 | 998 | 164 | $9,706 |
| Ofloxacin Generic | 569 | 595 | 333 | $7,359 |
| Brimonidine Tartrate Generic | 302 | 421 | 65 | $4,218 |
| Cyclosporine Generic | 244 | 311 | 94 | $82K |
| Azelastine Hcl Generic | 183 | 201 | 32 | $1,812 |
| Xiidra Lifitegrast | 123 | 145 | 43 | $96K |
| Erythromycin Erythromycin Base | 89 | 89 | 38 | $805 |
| Combigan Brimonidine Tartrate/Timolol | 87 | 116 | 19 | $20K |
| Timolol Maleate Generic | 80 | 97 | 16 | $664 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 70 | 70 | 49 | $476 |
| Rhopressa Netarsudil Mesylate | 70 | 72 | Under 11 | $23K |
| Ketorolac Tromethamine Generic | 66 | 69 | 29 | $975 |
Brand drugs: 3,483 claims; generic drugs: 3,652 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joann Kang $278 ($278 in general payments such as food, travel and fees) from 5 companies. The largest payer was Dompe US, Inc. with $88.55.
| Company | Payments | Amount |
|---|---|---|
| Dompe US, Inc. | 1 | $88.55 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 2 | $56.52 |
| Alcon Vision LLC ALC | 2 | $53.46 |
| Johnson & Johnson Surgical Vision, Inc. JNJ | 1 | $42.76 |
| Tarsus Pharmaceuticals, Inc. TARS | 1 | $36.69 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.